Thyrocare
Signals mentioning Thyrocare
- PharmEasy’s debt burden raises concerns over business stability and Thyrocare integration
- PharmEasy’s Thyrocare acquisition puts diagnostics at the centre of its health platform
- Inc42 flags PharmEasy’s debt burden and potential Thyrocare franchise challenges
- Inc42 flags debt-stress questions at PharmEasy, citing Thyrocare franchise concerns
- Inc42 examines how PharmEasy executed its Thyrocare acquisition
- PharmEasy faces scrutiny over debt burden and Thyrocare franchise issues
- Inc42 flags debt pressure at PharmEasy and franchise issues linked to Thyrocare
- PharmEasy’s Ghatkopar team drove Thyrocare acquisition
- Inc42 flags debt stress at PharmEasy and Thyrocare franchise concerns
- PharmEasy’s Thyrocare deal deepens its diagnostics play
- Inc42 flags debt stress and Thyrocare franchise concerns at PharmEasy
- PharmEasy’s Thyrocare deal strengthens its diagnostics play in consumer health
- PharmEasy Faces Fresh Scrutiny Over Debt and Thyrocare Franchise Issues
- PharmEasy’s Thyrocare acquisition revisited in Inc42 feature
- PharmEasy Faces Fresh Scrutiny Over Debt, Thyrocare Deal and Franchise Issues
- PharmEasy's 2021 acquisition of Thyrocare resurfaces, marking expansion from online pharmacy into diagnostics
- PharmEasy Debt Pressure and Thyrocare Franchise Issues Resurface from July 2023
- Inside PharmEasy’s acquisition of diagnostics player Thyrocare
- Inc42 flags debt concerns around PharmEasy, resurfacing a July 2023 report
- PharmEasy’s Thyrocare acquisition spotlights its diagnostics push